Go Pro
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
$120,000.00
$120,000.00
$120,000.00
▼
$120,000.00
N/A0.01N/AN/A
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
$1.62
+87.2%		$2.58
$0.82
▼
$75.00
$2.77M-1.77650,990 shs60.01 million shs
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$4.74
-2.8%		$4.99
$4.49
▼
$14.62
$237.05M0.97485,705 shs380,527 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
0.00%0.00%0.00%0.00%0.00%
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
-3.87%-5.53%-74.99%-76.55%-98.85%
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
+0.43%+0.31%+0.83%-3.77%-59.70%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
$120,000.00
$120,000.00
$120,000.00
▼
$120,000.00
N/A0.01N/AN/A
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
$1.62
+87.2%		$2.58
$0.82
▼
$75.00
$2.77M-1.77650,990 shs60.01 million shs
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$4.74
-2.8%		$4.99
$4.49
▼
$14.62
$237.05M0.97485,705 shs380,527 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
0.00%0.00%0.00%0.00%0.00%
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
-3.87%-5.53%-74.99%-76.55%-98.85%
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
+0.43%+0.31%+0.83%-3.77%-59.70%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
0.00
N/AN/AN/A
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
1.00
SellN/AN/A
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest NUS, BTCA, and MEDS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/14/2026
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Strong Sell
8/11/2026
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D+) ➝ Sell (D)
6/24/2026
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
(Data available from 9/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
N/AN/AN/AN/AN/AN/A
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
$23.34M0.22N/AN/A($6.94) per share-0.23
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$1.49B0.16$2.34 per share2.02$16.71 per share0.28
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
-$101.28M-$46.13N/AN/AN/A-1,100.16%N/A-171.81%N/A
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$160.20M-$4.47N/A4.08N/A-15.73%6.58%3.63%11/5/2026 (Estimated)

Latest NUS, BTCA, and MEDS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/10/2026Q2 2026
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$0.20$0.20N/A-$5.14$345.20 million$320.11 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
N/AN/AN/AN/AN/A
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
N/AN/AN/AN/AN/A
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
$0.245.07%-30.69%N/A N/A

Latest NUS, BTCA, and MEDS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/10/2026
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
quarterly$0.064.92%8/28/20268/28/20269/9/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
N/AN/AN/A
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
N/A
0.14
0.10
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
0.36
1.98
1.24

Institutional Ownership

CompanyInstitutional Ownership
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
N/A
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
5.68%
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
82.84%

Insider Ownership

CompanyInsider Ownership
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
41.40%
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
27.01%
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
2.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
126N/AN/ANot Optionable
Wellgistics Health, Inc. stock logo
MEDS
Wellgistics Health
313.20 million2.33 millionN/A
Nu Skin Enterprises, Inc. stock logo
NUS
Nu Skin Enterprises
2,80048.68 million47.31 millionOptionable

Recent News About These Companies

Nu Skin Ranked the World’s #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year
September 3, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/nu-skin-ranked-world-1-150000271.html
Nu Skin Announces EVP Medical Leave and Sales Oversight
August 21, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/nu-skin-announces-evp-medical-leave-and-sales-oversight?utm_source=marketbeat.com&utm_medium=referral
Why Nu Skin (NYSE:NUS) Retail Stock Draws Attention?
August 11, 2026  |  kalkinemedia.comK
Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2Q26
August 11, 2026  |  newsfilecorp.comN
Nu Skin Enterprises Q2 Earnings Meet Estimates, Revenues Down Y/Y
August 11, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2972811/nu-skin-enterprises-q2-earnings-meet-estimates-revenues-down-y-y?cid=cs-stocknewsapi-ft-analyst_blog|earnings_article-2972811
Nu Skin Enterprises (NUS) Matches Q2 Earnings Estimates
August 10, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2972304/nu-skin-enterprises-nus-matches-q2-earnings-estimates?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_4-2972304
Nu Skin Enterprises (NUS) Releases Q2 2026 Earnings: Revenue Falls and Loss Widens
August 10, 2026  |  quiverquant.comQ
Nu Skin Enterprises Reports Second Quarter Results
August 10, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260810531294/en/nu-skin-enterprises-reports-second-quarter-results/
Nu Skin Enterprises Announces Quarterly Dividend
August 10, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260810716012/en/nu-skin-enterprises-announces-quarterly-dividend/
Nu Skin Enterprises to Announce Second Quarter 2026 Financial Results
July 21, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260721689453/en/nu-skin-enterprises-to-announce-second-quarter-2026-financial-results/
Nu Skin Enterprises: Working Capital Intensity, A Lot Riding On India
June 30, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4918847-nu-skin-enterprises-working-capital-intensity-a-lot-riding-on-india
5 Undervalued Stocks With Attractive Price-to-Sales Ratios
June 30, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2945127/5-undervalued-stocks-with-attractive-price-to-sales-ratios?cid=cs-stocknewsapi-ft-analyst_blog|rw-2945127
5 Beauty & Cosmetics Stocks to Buy for a Stable Portfolio in 2H 2026
June 30, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2945228/5-beauty-cosmetics-stocks-to-buy-for-a-stable-portfolio-in-2h-2026?cid=cs-stocknewsapi-ft-analyst_blog|investment_ideas-2945228
Nu Skin (NUS) Soars 6.9%: Is Further Upside Left in the Stock?
June 29, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2944566/nu-skin-nus-soars-6-9-is-further-upside-left-in-the-stock?cid=cs-stocknewsapi-ft-tale_of_the_tape|daily_price_change_5%-2944566
4 Cosmetics Stocks Worth Watching on Favorable Industry Trends
June 17, 2026  |  zacks.comhttps://www.zacks.com/commentary/2938742/4-cosmetics-stocks-worth-watching-on-favorable-industry-trends?cid=cs-stocknewsapi-ft-industry_outlook-2938742
5 Value Stocks With Low Price-to-Sales Ratios & Massive Upside
June 16, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2938068/5-value-stocks-with-low-price-to-sales-ratios-massive-upside?cid=cs-stocknewsapi-ft-analyst_blog|rw-2938068
5 Bargain Low Price-to-Sales Stocks Positioned to Deliver Solid Gains
June 2, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2930776/5-bargain-low-price-to-sales-stocks-positioned-to-deliver-solid-gains?cid=cs-stocknewsapi-ft-analyst_blog|rw-2930776
Track Russell 3000 REIT shuffle: Reed's slated for addition as Skinhealth System exits
May 26, 2026  |  msn.comhttps://www.msn.com/en-us/money/topstocks/track-russell-3000-reit-shuffle-reed-s-slated-for-addition-as-skinhealth-system-exits/ar-AA247m0p
Nu Skin Enterprises Inc
May 21, 2026  |  cnbc.comhttps://www.cnbc.com/quotes/%20NUS
5 Value Stocks Trading at Attractive Price-to-Sales Ratios
May 21, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2924832/5-value-stocks-trading-at-attractive-price-to-sales-ratios?cid=cs-stocknewsapi-ft-analyst_blog|rw-2924832

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Foldable Apple smartphone displayed on a table with a lit Apple logo and city skyline in the background.
Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
By Sam Quirke | August 30, 2026
BWXT logo centered inside a circular industrial reactor or turbine chamber with metallic blue and orange lighting.
BWX Technologies’ Army Reactor Win Could Redraw Its Nuclear Growth Story
By Jeffrey Neal Johnson | August 28, 2026
Magnifying glass highlighting an upward-trending green candlestick stock chart against a dark trading background.
When Unusual Volume Isn't Noise: 3 Small-Caps Sending Signals
By Chris Markoch | August 27, 2026
Apple TV set-top box and remote on a media stand, with the Apple TV logo displayed on the screen behind.
What Does Apple's TV Price Hike Say About Where the Stock Is Heading?
By Sam Quirke | September 2, 2026
Apple MacBook and AirPods on patio table as investor checks AAPL, spotlighting consumer tech demand.
Can Apple's New Boss Deliver a Blockbuster Product Launch?
By Sam Quirke | September 6, 2026
Bactolac Pharmaceutical stock logo

Bactolac Pharmaceutical OTCMKTS:BTCA

$120,000.00 0.00 (0.00%)
As of 09/18/2017

Bactolac Pharmaceutical, Inc. engages in the research, development and commercialization of vitamins and neutraceuticals. It offers nutritional supplements and shake powders, resveratrol, probiotics, multivitamins, antioxidant products, sports and hormone supplements, and weight loss and detoxification drugs. The company was founded by Pailla Malla Reddy in 1995 and is headquartered in Hauppauge, NY.

Wellgistics Health stock logo

Wellgistics Health NASDAQ:MEDS

$1.62 +0.75 (+87.22%)
As of 04:00 PM Eastern

Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. We are focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. In January 2023 and May 2023, Wellgistics Health entered into separate definitive agreements with the owners of Wood Sage and Wellgistics LLC, respectively, whereby Wellgistics Health would acquire all of the respective outstanding membership interests of Wood Sage and Wellgistics LLC. In June 2024, Wellgistics Health and Wood Sage entered into an amended and revised definitive agreement and closed on the Wood Sage Acquisition, thereby making Wood Sage a wholly owned subsidiary of Wellgistics Health. In connection with the Wood Sage Acquisition, Wellgistics Health acquired Wood Sage’s two operating subsidiaries, APS—a pharmaceutical technology hub—and CSP—a retail community specialty pharmacy. On August 30, 2024, Wellgistics Health closed on the Wellgistics Acquisition, thereby making Wellgistics LLC—a company focused on wholesale operations including the distribution and fulfillment of certain pharmaceutical medications to a network of independent pharmacies meant to improve market access to and patient outcomes regarding the medications—a wholly owned subsidiary of Wellgistics Health. As such, Wellgistics Health currently exists as a holding company with Wood Sage as a directly held intermediate holding company subsidiary, APS and CSP as indirect operating subsidiaries, and Wellgistics LLC as a direct operating subsidiary. On October 4, 2024, the Company changed its corporate name to “Wellgistics Health, Inc.” by filing a duly authorized Certificate of Amendment to its Certificate of Incorporation. Despite that Wellgistics Health only recently closed the Wood Sage Acquisition and the Wellgistics Acquisition during 2024, the three companies have shared common office space, comarketed solutions to the marketplace, and leveraged financial and back-office support prior to June 2024. As such, Wellgistics Health’s management believes that its close business relationships have and will continue to limit the need for post-closing integration. The mailing address of our principal executive office is 3000 Bayport Drive, Suite 950 Tampa, FL.

Nu Skin Enterprises stock logo

Nu Skin Enterprises NYSE:NUS

$4.74 -0.14 (-2.77%)
Closing price 03:59 PM Eastern
Extended Trading
$4.84 +0.11 (+2.22%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas